CN Patent
CN104356068A — 恩杂鲁胺新晶型及其制备方法
Assigned to Hangzhou Xin Bosi Biological Medicine Co Ltd · Expires 2015-02-18 · 11y expired
What this patent protects
本发明提供一种化学式(Ⅰ)所示的恩杂鲁胺的新晶型及其制备方法,具体而言,本发明公开了一种B1晶型恩杂鲁胺及其制备方法。本发明所制备的恩杂鲁胺晶型稳定,溶解性好,适合药物开发;所用制备方法安全简便、可操作性强。
USPTO Abstract
本发明提供一种化学式(Ⅰ)所示的恩杂鲁胺的新晶型及其制备方法,具体而言,本发明公开了一种B1晶型恩杂鲁胺及其制备方法。本发明所制备的恩杂鲁胺晶型稳定,溶解性好,适合药物开发;所用制备方法安全简便、可操作性强。
Drugs covered by this patent
- Xtandi (enzalutamide) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.